Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
4.785
-0.095 (-1.95%)
Apr 25, 2025, 12:46 PM EDT - Market open

Avalo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
51787471914,212
Upgrade
Market Cap Growth
965.79%965.79%-84.63%-75.15%-95.47%-77.67%
Upgrade
Enterprise Value
-82-1-1521534,180
Upgrade
Last Close Price
4.887.439.101209.614895.967603.14
Upgrade
PS Ratio
48.98176.293.792.6335.37628.78
Upgrade
PB Ratio
0.380.581.00-4.358.27171.49
Upgrade
P/TBV Ratio
0.430.63--22.11491.62
Upgrade
EV/Sales Ratio
---2.8728.36624.03
Upgrade
Debt / Equity Ratio
0.010.010.26-1.981.530.06
Upgrade
Asset Turnover
0.010.010.070.320.090.17
Upgrade
Inventory Turnover
---896.212444.832074.05
Upgrade
Quick Ratio
19.4219.421.640.682.991.53
Upgrade
Current Ratio
19.9519.951.820.743.111.71
Upgrade
Return on Equity (ROE)
-50.06%-50.06%--684.77%-354.08%-282.65%
Upgrade
Return on Assets (ROA)
-29.75%-29.75%-53.91%-32.95%-82.82%-74.02%
Upgrade
Return on Capital (ROIC)
-35.69%-35.69%-146.88%-54.11%-121.58%-122.42%
Upgrade
Earnings Yield
-67.45%-45.18%-432.43%-87.80%-44.19%-1.51%
Upgrade
FCF Yield
-94.20%-63.10%-422.75%-56.58%-37.19%-0.96%
Upgrade
Buyback Yield / Dilution
-2599.19%-2599.19%-608.45%-8.32%-41.86%-28.52%
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q